STAT3 and COVID-19: In agreement with Schulte-Schrepping’s report in which STAT3 was suspected as transcriptional factor of immunosuppressive monocytes in COVID-19, we demonstrated that immunosuppression by monocytes isolated from COVID-19 patients can be indeed reverted by STAT3 inhibitors (Supplementary information, Fig. S5E).